IQVIA Holdings stock trades at EUR 239.40 with plus 0.02 percent

Published on 09/29/2026 at 15:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

IQVIA Holdings stock was at EUR 239.40 on September 29, 2026, plus 0.02 percent versus EUR 239.35. Q2 revenue reached USD 4.37 billion, up 8.7 percent year over year.

Modernes Pharmaforschungslabor mit Wissenschaftlern an Datenanalysesystemen — IQVIA Holdings betreibt ein modernes Pharmaforschungslabor US46266C1053 mit Wissenschaftlern an klinischen Datenanalysesystemen, Illustration mit AI erstellt.

IQVIA Holdings (ISIN US46266C1053) was trading at EUR 239.40 at Lang & Schwarz on September 29, 2026, plus 0.02 percent versus the prior close of EUR 239.35. The company enters its next reporting phase after second-quarter revenue reached USD 4.37 billion and EPS came in at USD 3.15, according to MarketBeat.

Revenue growth supports the setup

IQVIA's Q2 2026 revenue was up 8.7 percent from the same quarter a year earlier, while EPS exceeded the USD 3.03 consensus estimate by USD 0.12, MarketBeat reported. The comparison matters because the earnings beat came alongside higher sales, rather than from cost control alone.

Management's FY 2026 EPS guidance stands at USD 12.80-13.00, compared with the USD 11.56 average analyst estimate cited by MarketBeat. That range places the company guidance above the cited consensus midpoint and gives the October report a clear numerical benchmark.

Analyst targets move higher

Morgan Stanley lifted its IQVIA price objective from USD 240.00 to USD 270.00 and retained an equal-weight rating in a September 17, 2026 research note, as reported by MarketBeat. Separately, MarketScreener reported on September 1, 2026 that HSBC raised its target from USD 280.00 to USD 300.00 while maintaining a buy rating.

The two target revisions point in the same direction, but the ratings differ: Morgan Stanley stayed equal weight while HSBC retained a buy view. For investors, the key test is whether revenue growth and the USD 12.80-13.00 EPS guidance range remain intact at the next update.

October report sets the next checkpoint

IQVIA's next quarterly reporting date is October 27, 2026, according to the event calendar published by wallstreetONLINE. Until then, the current valuation context is defined by a market capitalization of USD 44.6 billion and a 52-week range of USD 154.50 to USD 277.40 as of September 29, 2026.